Surgery Partners (NASDAQ:SGRY) Shares Up 3.6%

Surgery Partners, Inc. (NASDAQ:SGRYGet Free Report)’s share price rose 3.6% during trading on Tuesday . The company traded as high as $23.93 and last traded at $23.92. Approximately 144,889 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 922,019 shares. The stock had previously closed at $23.08.

Analyst Upgrades and Downgrades

SGRY has been the topic of a number of recent analyst reports. Citigroup reduced their price objective on Surgery Partners from $42.00 to $38.00 and set a “buy” rating on the stock in a research note on Wednesday, May 8th. StockNews.com raised Surgery Partners from a “sell” rating to a “hold” rating in a research note on Thursday, March 21st. Macquarie began coverage on Surgery Partners in a research report on Friday, June 28th. They set an “outperform” rating and a $31.00 target price for the company. Benchmark restated a “buy” rating and set a $50.00 target price on shares of Surgery Partners in a research report on Wednesday, May 1st. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $43.00 target price on shares of Surgery Partners in a research report on Tuesday. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $41.38.

View Our Latest Report on Surgery Partners

Surgery Partners Stock Up 8.7 %

The business has a fifty day moving average of $25.26 and a 200 day moving average of $28.33. The firm has a market cap of $3.25 billion, a P/E ratio of 26.84, a P/E/G ratio of 1.75 and a beta of 2.78. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 0.92.

Surgery Partners (NASDAQ:SGRYGet Free Report) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. The business had revenue of $717.40 million during the quarter, compared to the consensus estimate of $707.66 million. Surgery Partners had a return on equity of 3.65% and a net margin of 0.02%. On average, equities research analysts predict that Surgery Partners, Inc. will post 0.88 EPS for the current year.

Insider Activity at Surgery Partners

In other Surgery Partners news, insider Danielle Burkhalter sold 6,000 shares of the business’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $26.39, for a total value of $158,340.00. Following the completion of the transaction, the insider now directly owns 30,354 shares of the company’s stock, valued at $801,042.06. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SGRY. Strs Ohio acquired a new position in shares of Surgery Partners during the fourth quarter worth about $51,000. DekaBank Deutsche Girozentrale boosted its position in shares of Surgery Partners by 102.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock worth $80,000 after buying an additional 1,375 shares during the period. Mesirow Institutional Investment Management Inc. boosted its position in shares of Surgery Partners by 12.4% during the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 3,388 shares of the company’s stock worth $108,000 after buying an additional 373 shares during the period. Headlands Technologies LLC acquired a new position in shares of Surgery Partners during the fourth quarter worth about $145,000. Finally, EntryPoint Capital LLC boosted its position in shares of Surgery Partners by 257.1% during the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock worth $191,000 after buying an additional 4,607 shares during the period.

About Surgery Partners

(Get Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Further Reading

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.